Boots courts +£11bn in UK high-street care race
This article was originally published in Clinica
Executive Summary
The final outcome of the race between US consortium Kohlberg Kravis Roberts (KKR) and Terra Firma to buy UK pharmacy, healthcare services and beauty group Alliance Boots could have implications for the wider UK independent healthcare sector. Today, the KKR-led company AB Acquisitions raised its offer for Boots, valuing it at £11.1bn ($22.2bn), trumping an "indicative proposal" from UK-based private equity group Terra Firma, worth £10.8bn.